Is Tirzepatide the Same as Mounjaro?

The misconception worth clearing up first

A common assumption is that tirzepatide and Mounjaro are different products, perhaps that tirzepatide is a generic version, or that Mounjaro contains something extra. It is an easy mistake to make. When you read clinical trial papers, regulatory documents and NHS guidance they almost always use the name tirzepatide; when you pick up the pen from the fridge, the box says Mounjaro. That gap between scientific language and brand language is where the confusion lives, and it is entirely understandable.

In reality the relationship is straightforward: tirzepatide is the international non-proprietary name (INN) for the molecule, and Mounjaro is the brand Eli Lilly registered with the MHRA to sell it. Every strength available in the UK (2.5 mg through to 15 mg) contains tirzepatide as its active substance. There is no generic tirzepatide on the UK market; Mounjaro is the only licensed form. If you have seen products described as tirzepatide peptide sold separately, those are unlicensed research-grade compounds, not the medicine in Mounjaro pens.

So when a prescriber writes a prescription for tirzepatide, the dispensed product is a Mounjaro KwikPen. The names are interchangeable in clinical conversation because they describe the same thing.

What tirzepatide actually does, and why the dual mechanism matters

Understanding the science makes the naming question easier to follow. Tirzepatide is a dual GIP and GLP-1 receptor agonist, which sets it apart from older weight-loss injections that target only the GLP-1 pathway. You can read more about where it sits in the broader class of medicines on our GLP-1 and tirzepatide explainer. Activating both receptors affects appetite signalling, slows the rate at which the stomach empties and helps regulate blood sugar, the combination is why tirzepatide produced greater average weight loss than semaglutide 2.4 mg in the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine in 2025.

SURMOUNT-1, which randomised 2,539 adults with obesity, reported average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks. Those trial results are all published under the name tirzepatide, which is why anyone researching the evidence base will encounter the scientific name far more than the brand name. The NHS medicines page for tirzepatide is the patient-level resource; it covers the same drug you receive in a Mounjaro pen.

NICE recommended tirzepatide (TA1026, published December 2024) for NHS use under specific eligibility criteria, and that appraisal document refers exclusively to tirzepatide throughout, yet the medicine being appraised is the Mounjaro pen. Same drug, different naming convention depending on context.

How Mounjaro is licensed and prescribed in the UK

Mounjaro holds a UK marketing authorisation for weight management in adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. It is also licensed for type 2 diabetes management. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. Treatment starts at the 2.5 mg strength (a dose designed to let the body adjust) and is titrated upward by the prescriber over time.

Mounjaro carries a Black Triangle (▼) symbol, which means the MHRA requires additional monitoring while post-market safety data accumulates. That is standard for newer medicines, not a sign of unusual risk. Every pack comes with a Patient Information Leaflet that refers throughout to tirzepatide, because that is the INN the regulator uses. If the two names appearing side by side on the same leaflet is what prompted your search today, you are not alone, it trips up a lot of people seeing the pen for the first time.

For context on how pricing works for this medicine in the UK, our overview of the Eli Lilly UK price changes covers what happened to list prices from September 2025 onward. Separately, if you are planning any surgical procedure while on treatment, our guide on Mounjaro and general anaesthetic is worth reading before speaking to your anaesthetist.

Searching under different names: what you might be finding

People search for this relationship in several directions (is mounjaro the same as tirzepatide, is mounjaro same as tirzepatide, is tirzepatide same as mounjaro) because the name you encounter first depends on where you started reading. Researchers land on the scientific literature and find tirzepatide; patients who have been prescribed the medicine see Mounjaro on the pen; people comparing services see both and wonder whether they are being offered different products. They are not.

A separate query worth addressing: searches for Manjaro occasionally arise from a simple spelling variation, Manjaro is not a medicine. And questions about whether tirzepatide and Mounjaro are the same thing have a consistent answer regardless of phrasing: yes, in every clinically meaningful sense. You can also explore our full tirzepatide overview for a broader look at the evidence, the side-effect profile, and how treatment works in practice.

If you are weighing up your options and want to know whether this medicine might be appropriate for you, the right starting point is a clinical consultation rather than a product page. At nume, a GPhC-registered Independent Prescriber (a real clinician, not an automated screening tool) reviews every consultation the same day it is submitted. Check your eligibility by starting a free consultation and our prescribers will take it from there.